Swixx BioPharma to acquire Laboratorios Biopas.

Swixx BioPharma, a commercial platform dedicated to unlocking access to innovative medicines worldwide, agreed to acquire Laboratorios Biopas, a pharmaceutical company. Financial terms were not disclosed. "We look forward to working closely with the brilliant, dedicated professionals that Biopas has attracted across Latam," commented Lespinasse. "We shall work passionately, with respect for Biopas' personnel and entrepreneurial culture, to join the two companies and thereby create something greater than the sum of the two parts," Jean-Michel Lespinasse, Swixx BioPharma CEO.